GGrantIndex
← Leaderboards

Ronglai Shen

Sloan-Kettering Inst Can Research

$3,190,387
Attributed
$4,813,454
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $965.8K · FY201225
$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,813,454 · 8

By mechanism

P01$2,397,385 · 4
R01$1,198,468 · 1
R21$875,952 · 2
R25$341,649 · 1

Top collaborators

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Top investigators on “Data Analyses

Research focus

Data AnalysesGenomicsMutationValidationGenesMalignant NeoplasmsTargeted TreatmentResearch PersonnelCohortResearch Project GrantsStatistical MethodsSamplingDatabasesBiometryMolecularMolecular ProfilingCell LineDna Copy NumberClassificationResistanceTumorCustomNovel MarkerIndividual Patient

Grant awards (26)

Genomics Research Experience for Master's Students (GEMS) Fellowship$113,883
R25 · FY2025 · CA
Genomics Research Experience for Master's Students (GEMS) Fellowship$113,883
R25 · FY2024 · CA
Leveraging the Hidden Genome to Recover the Missing Heritability of Cancer$455,111
R21 · FY2023 · CA · contact PI
Harnessing Rare Variants for Tumor Classification$396,790
R01 · FY2023 · CA · contact PI
Genomics Research Experience for Master's Students (GEMS) Fellowship$113,883
R25 · FY2023 · CA
Harnessing Rare Variants for Tumor Classification$396,790
R01 · FY2022 · CA · contact PI
Core 1: Biostatistics and Bioinformatics$272,363
P01 · FY2022 · CA · contact PI
Harnessing Rare Variants for Tumor Classification$404,888
R01 · FY2021 · CA · contact PI
Core 1: Biostatistics and Bioinformatics$277,922
P01 · FY2021 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$160,910
P01 · FY2021 · CA · contact PI
Core 1: Biostatistics and Bioinformatics$277,922
P01 · FY2020 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$37,556
P01 · FY2020 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$11,996
P01 · FY2020 · CA · contact PI
Core 1: Biostatistics and Bioinformatics$150,983
P01 · FY2019 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$111,083
P01 · FY2019 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$9,297
P01 · FY2019 · CA · contact PI
Core 1: Biostatistics and Bioinformatics$155,654
P01 · FY2018 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$114,519
P01 · FY2018 · CA · contact PI
Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome$127,396
P01 · FY2017 · CA · contact PI
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis$191,291
R21 · FY2016 · CA · contact PI
Biostatistics and Bioinformatics$140,456
P01 · FY2016 · CA · contact PI
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis$229,550
R21 · FY2015 · CA · contact PI
Biostatistics and Bioinformatics$140,456
P01 · FY2015 · CA · contact PI
Biostatistics and Bioinformatics$133,013
P01 · FY2014 · CA · contact PI
Biostatistics and Bioinformatics$132,027
P01 · FY2013 · CA · contact PI
Biostatistics and Bioinformatics$143,832
P01 · FY2012 · CA · contact PI